PHILADELPHIA, May 27, 2025 (GLOBE NEWSWIRE) -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against Viatris Inc. (“Viatris” or the “Company”) (NASDAQ: VTRS) on behalf of purchasers of Viatris securities between August 8, 2024 through February 26, 2025, inclusive (the “Class Period”). Investor Deadline: Investors who purchased or acquired Viatris securities during the Class Period may, no later than JUNE 3, 2025, seek to be appointed as a lead plaintiff represent ...

证券代码：600839 证券简称：四川长虹 公告编号：临 2025-038 号 四川长虹电器股份有限公司 关于公司下属控股子公司涉及诉讼的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ●案件所处的诉讼阶段：一审已判决（尚在上诉期内，判决尚未生效） ●四川长虹电器股份有限公司（以下简称"公司"或"四川长虹"）下属公 司在案件中的当事人地位：原告 ●案件的涉案金额：判决被告苏宁易购集团股份有限公司苏宁采购中心（以 下简称"苏宁采购中心"）支付原告四川长虹佳华数字技术有限公司（以下简称 " 佳 华 数 字 " ） 货 款 本 金 720,466,948.25 元 、 资 金 占 用 损 失 包 括 以 同期全国银行间同业拆借中心公布的一年期贷款市场报价利率的 1.3 倍计算至 实际付清之日止的损失。案件受理费 4,444,655 元，由原告佳华数字负担 32,518 元，由被告苏宁采购中心、苏宁易购集团股份有限公司（以下简称"苏宁易购"）、 包头苏宁易购销售有限公司（以下简称"包头苏宁"）、大庆苏宁易购销 ...

Core Viewpoint - Civitas Resources, Inc. is facing a class action lawsuit due to alleged misleading statements regarding its oil production and financial condition during the class period from February 27, 2024, to February 24, 2025 [1][3]. Group 1: Class Action Details - The Rosen Law Firm is reminding investors who purchased Civitas securities during the class period of the July 1, 2025, deadline to become a lead plaintiff in the class action [1][2]. - The lawsuit claims that Civitas made materially false statements and failed to disclose significant risks, including a likely reduction in oil production in 2025 and the need for additional debt to acquire more acreage [3]. Group 2: Allegations Against Civitas - Allegations include that Civitas would need to implement disruptive cost-reduction measures, including significant workforce reductions, due to its financial condition [3]. - The lawsuit asserts that Civitas' public statements regarding its business and financial prospects were overstated, leading to investor damages when the true situation was revealed [3]. Group 3: Rosen Law Firm's Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements and being recognized for its success in the field [4]. - The firm emphasizes the importance of selecting qualified legal counsel with experience in leading securities class actions [4].

Core Viewpoint - A class action lawsuit has been filed against Napco Security Technologies, Inc. for allegedly misleading investors about its growth projections and sales performance during the fiscal year 2025 [1][2]. Allegations - The lawsuit claims that Napco failed to disclose its true ability to forecast product demand and its negotiating position with distributors, leading to inflated long-term growth projections [2]. - Napco attributed its declining hardware sales to one-off setbacks, while the complaint suggests that the company's forecasting processes were inadequate [2]. Financial Impact - On February 3, 2025, Napco reported disappointing financial results for Q2 of fiscal 2025, showing a significant drop in hardware sales [3]. - Following this announcement, Napco's stock price fell from $36.70 per share on January 31, 2024, to $26.93 per share on February 3, 2025, marking a decline of approximately 26.62% in one day [3]. Class Action Participation - Shareholders interested in serving as lead plaintiffs must file their papers by June 24, 2025, but participation is not required to be eligible for recovery [4]. - The representation in the class action is on a contingency fee basis, meaning shareholders will not incur any fees or expenses [5].

Core Viewpoint - The Organon class action lawsuit alleges that the company and its executives made misleading statements regarding capital allocation and dividend payouts, leading to significant financial losses for investors [1][4][5]. Company Overview - Organon & Co. develops health solutions through prescription therapies and medical devices [3]. Allegations of the Lawsuit - The lawsuit claims that Organon concealed material information about its capital allocation priorities, particularly regarding the future of its quarterly dividend payout [4]. - It is alleged that Organon's reports on dividend payouts being a "number one priority" were misleading, as they were countered by a newly implemented debt reduction strategy, resulting in a more than 70% decrease in the quarterly dividend [4]. - Following the acquisition of Dermavant Sciences Ltd., Organon prioritized debt reduction, which was not disclosed to investors [4]. Financial Impact - On May 1, 2025, Organon reported its first quarter 2025 financial results, announcing a drastic reduction in its dividend payout from $0.28 to $0.02, which led to a more than 27% drop in the stock price [5]. Legal Process - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased Organon securities during the class period to seek appointment as lead plaintiff in the lawsuit [6]. - The lead plaintiff represents the interests of all class members and can select a law firm for litigation [6]. Law Firm Background - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder litigation, having recovered over $2.5 billion for investors in 2024 alone [7]. - The firm has been ranked 1 in securing monetary relief for investors in securities class action cases for four out of the last five years [7].

NEW YORK, May 23, 2025 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Organon & Co. (“Organon” or the “Company”) (NYSE: OGN) between October 31, 2024, to April 30, 2025, both dates inclusive. You are hereby notified that the class action lawsuit Joseph Hauser v. Organon & Co., et al. (Case No. 2:25-cv-05322) has been commenced in the United States District Court for the District of New Jersey ...

NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Ultra Clean Holdings, Inc. (NASDAQ: UCTT) between May 6, 2024 to February 24, 2025, both dates inclusive (the “Class Period”), of the important May 23, 2025 lead plaintiff deadline. SO WHAT: If you purchased Ultra Clean securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangem ...

Core Viewpoint - Robbins LLP is investigating Proficient Auto Logistics, Inc. for potential violations of securities laws and breaches of fiduciary duties by its officers and directors [1]. Group 1: Company Overview - Proficient Auto Logistics, Inc. operates in the auto transportation and logistics services sector in North America [1]. Group 2: Legal Investigation - The investigation by Robbins LLP aims to determine if there have been any breaches of fiduciary duties to shareholders by the company's executives [1]. - Shareholders who have incurred losses in their investments are encouraged to contact Robbins LLP for more information regarding their rights [2]. Group 3: Robbins LLP Background - Robbins LLP has been active in shareholder rights litigation since 2002, focusing on helping shareholders recover losses and improve corporate governance [3]. - The firm has successfully obtained over $1 billion for shareholders since its inception [3].

NEW YORK, May 20, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of NET Power Inc. (NYSE: NPWR, NPWR.WS) between June 9, 2023 and March 7, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 17, 2025. SO WHAT: If you purchased NET Power securities during the Class Period you may be entitled to compensation without p ...

SAN DIEGO, May 20, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of West Pharmaceutical Services, Inc. (NYSE: WST) common stock between February 16, 2023 and February 12, 2025, inclusive (the “Class Period”), have until Monday, July 7, 2025 to seek appointment as lead plaintiff of the West Pharmaceutical class action lawsuit. Captioned New England Teamsters Pension Fund v. West Pharmaceutical Services, Inc., No. 25-cv-02285 (E.D. Pa.), the West Pharmaceutic ...